Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Prime Medicine (PRME) Assets Average: 2022-2025

Historic Assets Average for Prime Medicine (PRME) over the last 3 years, with Sep 2025 value amounting to $332.0 million.

  • Prime Medicine's Assets Average rose 12.07% to $332.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $332.0 million, marking a year-over-year increase of 12.07%. This contributed to the annual value of $245.7 million for FY2024, which is 11.33% down from last year.
  • Latest data reveals that Prime Medicine reported Assets Average of $332.0 million as of Q3 2025, which was up 9.36% from $303.6 million recorded in Q2 2025.
  • Prime Medicine's Assets Average's 5-year high stood at $338.6 million during Q1 2023, with a 5-year trough of $216.5 million in Q4 2023.
  • Its 3-year average for Assets Average is $292.0 million, with a median of $298.9 million in 2023.
  • Within the past 5 years, the most significant YoY rise in Prime Medicine's Assets Average was 45.57% (2024), while the steepest drop was 25.40% (2024).
  • Over the past 4 years, Prime Medicine's Assets Average (Quarterly) stood at $287.8 million in 2022, then dropped by 24.77% to $216.5 million in 2023, then spiked by 45.57% to $315.1 million in 2024, then climbed by 12.07% to $332.0 million in 2025.
  • Its Assets Average was $332.0 million in Q3 2025, compared to $303.6 million in Q2 2025 and $312.8 million in Q1 2025.